REOPERACE PRO NITROBRISNI KRVACENI. = REINTERVENTIONS POUR HEMORRAGIES INTRAABDOMINALESKNOBLOCH J; CERNY T.1978; ROZHL. V CHIR.; CSK; DA. 1978; VOL. 57; NO 5; PP. 360-364; ABS. RUS/ENG; BIBL. 18 REF.Article

The enigma of ifosfamide encephalopathyCERNY, T; KÜPFER, A.Annals of oncology. 1992, Vol 3, Num 9, pp 679-681, issn 0923-7534Article

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesLEYVRAZ, S; HERRMANN, R; PESTALOZZI, B et al.British journal of cancer. 2006, Vol 95, Num 10, pp 1342-1347, issn 0007-0920, 6 p.Article

Analgesic action of i.v. morphine-6-glucuronide in healthy volunteersBUETLER, T. M; WILDER-SMITH, O. H. G; WILDER-SMITH, C. H et al.British Journal of Anaesthesia. 2000, Vol 84, Num 1, pp 97-99, issn 0007-0912Article

Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapyVON ROHR, E; GÖNNER, F; SCHROTH, G et al.Journal of clinical neuroscience. 1999, Vol 6, Num 3, pp 247-249, issn 0967-5868Article

Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapyAESCHLIMANN, C; KÜPFER, A; SCHEFER, H et al.Drug metabolism and disposition. 1998, Vol 26, Num 9, pp 883-890, issn 0090-9556Conference Paper

Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blueAESCHLIMANN, C; CERNY, T; KÜPFER, A et al.Drug metabolism and disposition. 1996, Vol 24, Num 12, pp 1336-1339, issn 0090-9556Article

Early versus late alternating chemotherapy in small-cell lung cancerJOSS, R. A; BACCHI, M; LUDWIG, C et al.Annals of oncology. 1995, Vol 6, Num 2, pp 157-166, issn 0923-7534Article

Docetaxel (Taxotere^TM) is active in non-small-cell lung cancer : a phase II trial of the EORTC early clinical trials group (ECTG)CERNY, T; KAPLAN, S; PAVLIDIS, N et al.British journal of cancer. 1994, Vol 70, Num 2, pp 384-387, issn 0007-0920Article

Depletion of circulating cyst(e)ine by oral and intravenous mesnaSTOFER-VOGEL, B; CERNY, T; KÜPFER, A et al.British journal of cancer. 1993, Vol 68, Num 3, pp 590-593, issn 0007-0920Article

The symptomatic control of cytostatic drug-induced emesis. A recent history and reviewJOSS, R. A; BRAND, B. C; BUSER, K. S et al.European journal of cancer & clinical oncology. 1990, Vol 26, pp S2-S8, issn 0277-5379, suppl. 1Conference Paper

Effect of in vivo administration of interferon gamma on expression of MHC products and tumour associated antigens in patients with metastatic melanomaGHOSH, A. K; CERNY, T; WAGSTAFF, J et al.European journal of cancer & clinical oncology. 1989, Vol 25, Num 11, pp 1637-1643, issn 0277-5379, 7 p.Article

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunctionJOERGER, M; HUITEMA, A. D. R; KOEBERLE, D et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 113-124, issn 0344-5704, 12 p.Article

Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II studyVON ROHR, A; SCHMITZ, S.-F. H; RUFENER, B et al.Annals of oncology. 2002, Vol 13, Num 10, pp 1641-1649, issn 0923-7534, 9 p.Article

The effect of Rituximab on patients with follicular and mantle-cell lymphomaGHIELMINI, M; SCHMITZ, S.-F. H; CERNY, T et al.Annals of oncology. 2000, Vol 11, pp 123-126, issn 0923-7534, SUP1Conference Paper

Multiple drug resistance parameter expression in ovarian cancerJONCOURT, F; BUSER, K; ALTERMATT, H et al.Gynecologic oncology (Print). 1998, Vol 70, Num 2, pp 176-182, issn 0090-8258Article

Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancerPAGANI, O; SESSA, C; MARTINELLI, G et al.Annals of oncology. 1997, Vol 8, Num 7, pp 655-661, issn 0923-7534Article

Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemiaBETTICHER, D. C; SCHMITZ, S.-F. H; RATSCHILLER, D et al.British journal of haematology. 1997, Vol 99, Num 2, pp 358-363, issn 0007-1048Article

Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer ? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincritine and lomustineJOSS, R. A; ALBERTO, P; HÜRNY, C et al.Annals of oncology. 1995, Vol 6, Num 1, pp 41-48, issn 0923-7534Article

A phase II study of I proplatin in advanced or metastatic stomach cancerSESSA, C; CERNY, T; KAYE, S et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 1, pp 61-62, issn 0277-5379Article

Relationships among cell survival, O⁶-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell linesMAYNARD, K; PARSONS, P. G; CERNY, T et al.Cancer research (Baltimore). 1989, Vol 49, Num 17, pp 4813-4817, issn 0008-5472Article

Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)CERNY, T; PEDRAZZINI, A; JOSS, R. A et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 11, pp 1791-1794, issn 0277-5379Article

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer : 5-year follow-up of a phase II studyBETTICHER, D. C; HSU SCHMITZ, S.-F; SPILIOPOULOS, A et al.British journal of cancer. 2006, Vol 94, Num 8, pp 1099-1106, issn 0007-0920, 8 p.Article

Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system : a study of the Swiss Group for Clinical Cancer Research (SAKK)GHIELMINI, M; RUFIBACH, K; KETTERER, N et al.Annals of oncology. 2005, Vol 16, Num 10, pp 1675-1682, issn 0923-7534, 8 p.Article

Pneumococcal vaccine in patients with absent or dysfunctional spleenKOBEL, D.-E; FRIEDL, A; CERNY, T et al.Mayo Clinic proceedings. 2000, Vol 75, Num 7, pp 749-753, issn 0025-6196Article